<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05627206</url>
  </required_header>
  <id_info>
    <org_study_id>PM+FMZam</org_study_id>
    <nct_id>NCT05627206</nct_id>
  </id_info>
  <brief_title>The Impact of PM+For Moms Intervention on Improving Mother's Mental Health in Zambia (PM+FM)</brief_title>
  <acronym>PM+FM</acronym>
  <official_title>The Impact of PM+For Moms Intervention on Improving Mother's Mental Health in Zambia (PM+FM)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Swiss Tropical &amp; Public Health Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Innovations for Poverty Action</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Swiss Tropical &amp; Public Health Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      CMHD are particularly prevalent among women, posing a major threat to their own and their&#xD;
      children's wellbeing.&#xD;
&#xD;
      Despite the high prevalence of CMHD and the existence of effective treatments, interventions&#xD;
      supporting women living in low-resourced settings remain limited.&#xD;
&#xD;
      This study builds on a parent study (Zamcharts NCT03991182), which identified a high&#xD;
      prevalence of women with anxiety and/or depression. We propose to design, test, and validate&#xD;
      a community-based intervention nested within the public primary health system in Zambia, to&#xD;
      identify and treat women with mild-to-severe CMHDs.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 15, 2022</start_date>
  <completion_date type="Anticipated">December 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Anxiety and Depression symptoms.</measure>
    <time_frame>Used for the pre-post treatment analysis. Change between Baseline (at enrollment) and 4 months after enrollment</time_frame>
    <description>HSCL-25. 10 questions anxiety, 15 depression; (Î± = 0.90).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Mental health symptoms. SRQ-20</measure>
    <time_frame>Change between Baseline (at enrollment) and 6 months after enrollment</time_frame>
    <description>20 items measuring risk of common mental health problem.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Feasibility of the study</measure>
    <time_frame>Assessed 4 months after enrollment</time_frame>
    <description>% of 1 or more sessions completed. Qualitative feedback from participants and providers.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acceptability</measure>
    <time_frame>Assessed 4 months after enrollment</time_frame>
    <description>% of participants completing more than 6 sessions. Qualitative feedback from participants and providers.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Mental health symptoms. PSYCHLOPS</measure>
    <time_frame>Used for the pre-post treatment analysis. Change between Baseline (at enrollment) and 4 months after enrollment</time_frame>
    <description>Psychological Outcome Profiles (5 items)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functionality</measure>
    <time_frame>Used for the pre-post treatment analysis. Change between Baseline (at enrollment) and 4 months after enrollment</time_frame>
    <description>WHO-DAS2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>World Bank's Toolkit and Inventory</measure>
    <time_frame>Used for the pre-post treatment analysis. Change between Baseline (at enrollment) and 4 months after enrollment</time_frame>
    <description>Selected measures from the World Bank Toolkit to address mother-child interactions and child early development.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Depressive Symptoms</condition>
  <condition>Anxiety</condition>
  <condition>Trauma, Psychological</condition>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Problem Management + For Moms</intervention_name>
    <description>Psychosocial intervention conducted by a trained Wellbeing-Community health worker. Adapted from Problem Management +, thinking healthy and Strong Minds-Strong Communities intervention to target women with small children and mental health symptoms living in low-resourced settings. Combines several evidence-based strategies such us psychoeducational, motivational interviewing, cognitive restructuring and relaxation exercises. Organized in 10 weekly sessions (8 individual 2 in group) provided in-person, by phone or virtually.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women participating in ZamCharts parent study&#xD;
&#xD;
          -  SRQ-20 &gt;7 (clinically significant symptoms of depression or/anxiety),&#xD;
&#xD;
          -  with 1 hour a week availability&#xD;
&#xD;
          -  not planning to move within the next 6 months,&#xD;
&#xD;
          -  with capacity to consent&#xD;
&#xD;
          -  not receiving current mental health care.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women with active suicidal ideation (determined by Paykel=4 OR 5),&#xD;
&#xD;
          -  severe substance use (ACOK-SUD &gt;3),&#xD;
&#xD;
          -  mania or psychotic symptoms&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Irene Falgas-Bague, M.D. PhD</last_name>
    <phone>+41784055878</phone>
    <email>irene.falgasbague@swisstph.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Innovatations for Poverty Action</name>
      <address>
        <city>Lusaka</city>
        <country>Zambia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tamara Billima</last_name>
    </contact>
    <contact_backup>
      <last_name>Mpela Chembe</last_name>
    </contact_backup>
    <investigator>
      <last_name>Thandiwe Tembo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Zambia</country>
  </location_countries>
  <verification_date>April 2023</verification_date>
  <study_first_submitted>November 7, 2022</study_first_submitted>
  <study_first_submitted_qc>November 23, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 25, 2022</study_first_posted>
  <last_update_submitted>April 24, 2023</last_update_submitted>
  <last_update_submitted_qc>April 24, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Swiss Tropical &amp; Public Health Institute</investigator_affiliation>
    <investigator_full_name>Irene Falgas Bague</investigator_full_name>
    <investigator_title>Post-Doctoral Research Collaborator</investigator_title>
  </responsible_party>
  <keyword>women</keyword>
  <keyword>low-resourced settings</keyword>
  <keyword>psychosocial intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Psychological Trauma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

